0.00Open0.00Pre Close0 Volume0 Open Interest9.00Strike Price0.00Turnover293.73%IV-47.37%PremiumDec 20, 2024Expiry Date8.10Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9588Delta0.0123Gamma2.07Leverage Ratio-0.0414Theta0.0017Rho1.99Eff Leverage0.0022Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet